HAS publishes Transparency Commission opinion for Keytruda

12 April 2017 - The opinion relates the use of pembrolizumab by patients with non-small-cell lung cancer. ...

Read more →

Agenda for 5 April 2017 TC meeting

31 March 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 22 March 2017 TC meeting

20 March 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for the 8 March 2017 TC meeting

3 March 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 22 February 2017 TC meeting

10 February 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 8 February 2017 TC meeting

3 February 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 25 January 2017 meeting

18 January 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 11 January 2017 TC meeting

6 January 2017 - HAS has posted the agenda for the first Transparency Commission meeting for 2017. ...

Read more →

Agenda for 7 December 2016 TC meeting

2 December 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 30 November 2016 TC meeting

24 November 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

France's High Authority of Health is in favour of delisting Alzheimer's disease drugs

22 October 2016 - The Transparency Committee, responsible for evaluating medicinal products within the High Authority of Health recommended against ...

Read more →

Agenda for 19 October Transparency Commission meeting

12 October 2016 - HAS has published the agenda for the next scheduled Transparency Commission meeting. ...

Read more →

Agenda for the 5 October 2016 TC meeting

28 September 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

TC opinion on Lyxumia finally published

26 September 2016 - The Transparency Commission has published its opinion on Sanofi's GLP-1 analogue. ...

Read more →

Agenda for 21 September 2016 TC meeting

19 September 2016 - The Transparency Commission will consider the reimbursement of a number of new medicines and blood products. ...

Read more →